3,898
Views
28
CrossRef citations to date
0
Altmetric
Back Matter

Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model

ORCID Icon, , , , , , , , , & show all
Article: 1729300 | Received 19 Aug 2019, Accepted 06 Jan 2020, Published online: 24 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Na Li, Zubin Li, Xin Li, Bingjie Chen, Huibo Sun & Kun Zhao. (2021) Identification of An Immune-Related Long Noncoding Rna Signature that Predicts Prognosis in Breast Cancer Patients. Biomarkers in Medicine 15:3, pages 167-180.
Read now

Articles from other publishers (27)

Courtney Chen, Audrey Jung, Annie Yang, Isabel Monroy, Zhifang Zhang, Shyambabu Chaurasiya, Supriya Deshpande, Saul Priceman, Yuman Fong, Anthony K. Park & Yanghee Woo. (2023) Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies. Cancers 15:23, pages 5661.
Crossref
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Sang-In Kim, Jianming Lu, Hannah Valencia, Yuman Fong & Yanghee Woo. (2023) Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients. International Journal of Molecular Sciences 24:18, pages 14189.
Crossref
Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh, Kirat K. Ganguly, Malini Basu & Mrinal K. Ghosh. (2023) Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. Genes & Diseases 10:4, pages 1318-1350.
Crossref
Simran Deep Kaur, Aman Deep Singh & Deepak N. Kapoor. (2023) Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy. Medical Oncology 40:7.
Crossref
Annie Yang, Zhifang Zhang, Shyambabu Chaurasiya, Anthony K Park, Audrey Jung, Jianming Lu, Sang-In Kim, Saul Priceman, Yuman Fong & Yanghee Woo. (2023) Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases. Journal for ImmunoTherapy of Cancer 11:4, pages e006280.
Crossref
Yuan Yuan, Colt Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Lin, Helen Chang, Leslie Mi Ok Chong, Amanda Seiz, Monil Shah, W. Hans Meisen, Aileen Tang, Norma Martinez, Wichanee Pickett, Mireya Murga, Susan E. Yost, Daphne Stewart, Jianying Zhang, Nicholas Ede, Badri Modi, Jonathan Kessler, Jamie Rand & Yuman Fong. (2023) CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. Therapeutic Advances in Medical Oncology 15.
Crossref
Yinan Shen, Wei Song, Danni Lin, Xiaozhen Zhang, Meng Wang, Yuwei Li, Zifan Yang, Sida Guo, Zijun Wang, Jianpeng Sheng, Yanal Murad, Jun Ding, Yufeng Lou, Xinping Pan, Zongsong Wu, Ronghua Zhao, Weiguo Jia, Xueli Bai & Tingbo Liang. (2022) VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes. Journal of Medical Virology 95:1.
Crossref
Richard Kolade Omole, Oluwaseyi Oluwatola, Millicent Tambari Akere, Joseph Eniafe, Elizabeth Oladoyin Agboluaje, Oluwafemi Bamidele Daramola, Yemisi Juliet Ayantunji, Temiloluwa Ifeoluwa Omotade, Nkem Torimiro, Modupe Stella Ayilara, Oluwole Isaac Adeyemi & Olubusola Sajanat Salinsile. (2022) Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy. Frontiers in Pharmacology 13.
Crossref
Ghazal Asadi Garmaroudi, Farzaneh Karimi, Leila Ghanbari Naeini, Pajman Kokabian & Nozar Givtaj. (2022) Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective. Oxidative Medicine and Cellular Longevity 2022, pages 1-14.
Crossref
Xiaoxiao Zhang, Xueying Ge, Tinghan Jiang, Ruming Yang & Sijie Li. (2022) Research progress on immunotherapy in triple‑negative breast cancer (Review). International Journal of Oncology 61:2.
Crossref
Hina Qayoom, Umar Mehraj, Shariqa Aisha, Shazia Sofi & Manzoor Ahmad Mir. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Jianming Lu, Sang-In Kim, Susanne G. Warner, Yate-Ching Yuan, Zheng Liu, Haiyong Han, Daniel Von Hoff, Yuman Fong & Yanghee Woo. (2021) CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. Cancer Gene Therapy 29:6, pages 722-733.
Crossref
Hao Deng, Bin Xiao, Yinger Huang, Kongyan Weng, Jialing Chen, Kun Li, Hongfeng Wu, Shuhong Luo & Wenbo Hao. (2022) The Combined Use of Orf Virus and PAK4 Inhibitor Exerts Anti-tumor Effect in Breast Cancer. Frontiers in Microbiology 13.
Crossref
Sang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, Seonah Kang, Anthony K. Park, Jianming Lu, Annie Yang, Zhifang Zhang, Isabella A. Bagdasarian, Yanghee Woo, Joshua T. Morgan, Zhirong Yin, Yuman Fong & Susanne G. Warner. (2022) Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer. Molecular Therapy - Oncolytics 24, pages 864-872.
Crossref
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Sang-In Kim, Jianming Lu, Tove Olafsen, Susanne G. Warner, Yuman Fong & Yanghee Woo. (2022) PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1. Molecular Therapy - Oncolytics 24, pages 331-339.
Crossref
Shyambabu Chaurasiya, Annie Yang, Zhifang Zhang, Jianming Lu, Hannah Valencia, Sang-In Kim, Yanghee Woo, Suanne G. Warner, Tove Olafsen, Yuqi Zhao, Xiwei Wu, Seymour Fein, Linda Cheng, Maria Cheng, Nicholas Ede & Yuman Fong. (2022) A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer. Molecular Therapy - Methods & Clinical Development 24, pages 102-116.
Crossref
Mary E. Carter, André Koch, Ulrich M. Lauer & Andreas D. Hartkopf. (2021) Clinical Trials of Oncolytic Viruses in Breast Cancer. Frontiers in Oncology 11.
Crossref
Shengye Jin, Qin Wang, Hao Wu, Da Pang & Shouping Xu. (2021) Oncolytic viruses for triple negative breast cancer and beyond. Biomarker Research 9:1.
Crossref
Shyambabu Chaurasiya, Sang-In Kim, Michael O’Leary, Anthony K. Park, Jianming Lu, Seonah Kang, Zhifang Zhang, Annie Yang, Yanghee Woo, Yuman Fong & Susanne G. Warner. (2021) Toward comprehensive imaging of oncolytic viroimmunotherapy. Molecular Therapy - Oncolytics 23, pages 303-310.
Crossref
Shyambabu Chaurasiya & Yuman Fong. (2020) Viroimmunotherapy for breast cancer: promises, problems and future directions. Cancer Gene Therapy 28:7-8, pages 757-768.
Crossref
Yaqi Zhao, Zheming Liu, Lan Li, Jie Wu, Huibo Zhang, Haohan Zhang, Tianyu Lei & Bin Xu. (2021) Oncolytic Adenovirus: Prospects for Cancer Immunotherapy. Frontiers in Microbiology 12.
Crossref
Amy Kwan, Natalie Winder & Munitta Muthana. (2021) Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances. Viruses 13:6, pages 1128.
Crossref
Guillermo Valdivia, Ángela Alonso-Diez, Dolores Pérez-Alenza & Laura Peña. (2021) From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review. Frontiers in Veterinary Science 8.
Crossref
Sang-In Kim, Anthony K. Park, Shyambabu Chaurasiya, Seonah Kang, Jianming Lu, Annie Yang, Venkatesh Sivanandam, Zhifang Zhang, Yanghee Woo, Saul J. Priceman, Yuman Fong & Susanne G. Warner. (2021) Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity. Molecular Cancer Therapeutics 20:1, pages 173-182.
Crossref
Sang-In Kim, Shyambabu Chaurasiya, Anthony K. Park, Seonah Kang, Jianming Lu, Yanghee Woo, Hongwei Holly Yin, Zhirong Yin, Yuman Fong & Susanne G. Warner. (2020) Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models. International Journal of Molecular Sciences 21:19, pages 7326.
Crossref
Benjamin Gordon & Vijayakrishna K. Gadi. (2020) The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines. Vaccines 8:3, pages 529.
Crossref
Shyambabu Chaurasiya, Yuman Fong & Susanne G. Warner. (2020) Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges. Cancers 12:6, pages 1699.
Crossref